The BRILLIANT program is scrambling to find money to save the project. The purchase of key equipment has stopped.

Just a week remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high ...

Jasper Therapeutics' valuation falls to $53M following drug development issues, leading to layoffs and a focus shift to ...